carvacrol has been researched along with Cytokine Release Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Albuquerque Júnior, RLC; de Carvalho, FO; de Souza Araújo, AA; Nunes, PS; Silva, ÉR; Silva, JPR | 1 |
| Cabello-Verrugio, C; Eltit, F; Gatica, S; Santibanez, JF; Simon, F; Varela, D | 1 |
1 review(s) available for carvacrol and Cytokine Release Syndrome
| Article | Year |
|---|---|
Would carvacrol be a supporting treatment option effective in minimizing the deleterious effects of COVID-19?
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Antioxidants; COVID-19; COVID-19 Drug Treatment; Cymenes; Cytokine Release Syndrome; Humans; Inflammation Mediators | 2021 |
1 other study(ies) available for carvacrol and Cytokine Release Syndrome
| Article | Year |
|---|---|
Expression Suppression and Activity Inhibition of TRPM7 Regulate Cytokine Production and Multiple Organ Dysfunction Syndrome During Endotoxemia: a New Target for Sepsis.
Topics: Adenoviridae; Animals; Cachexia; Cymenes; Cytokine Release Syndrome; Cytokines; Endotoxemia; Genetic Vectors; Hypoglycemia; Liver Failure; Multiple Organ Failure; Muscle, Skeletal; Myocardium; Rats; RNA Interference; RNA, Small Interfering; TRPM Cation Channels | 2019 |